Expression of integrin αvß3 in medullary thyroid carcinoma.
Future Oncol
; 20(27): 2015-2022, 2024.
Article
em En
| MEDLINE
| ID: mdl-39101553
ABSTRACT
Aim:
Tumor markers often remain elevated after intended curative resection of medullary thyroid carcinoma (MTC). The aim of this study was to determine the expression of αvß3, a promising theranostics target, in MTC and its metastases.Materials &methods:
Avß3 expression was analyzed in 104 patients using a tissue microarray and correlated with clinicopathological variables and survival.Results:
Cytoplasmic αvß3 positivity was seen in 70 patients and was associated with lymph node metastases at time of initial surgery. Membranous positivity was considered positive in 30 patients and was associated with sporadic MTC.Conclusion:
Avß3 was expressed in the cytoplasm of 67% of MTC patients. Membranous expression, which is presumably most relevant for the theranostic use of αvß3, was seen in 29%.
[Box see text].
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Neoplasias da Glândula Tireoide
/
Biomarcadores Tumorais
/
Carcinoma Neuroendócrino
/
Integrina alfaVbeta3
Limite:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Idioma:
En
Revista:
Future Oncol
Ano de publicação:
2024
Tipo de documento:
Article